SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,293,000 | -82.0% | 30,000 | -87.0% | 0.19% | -83.7% |
Q1 2017 | $7,199,000 | +14.0% | 230,000 | -8.0% | 1.14% | -5.8% |
Q4 2016 | $6,313,000 | -99.9% | 250,000 | -7.4% | 1.21% | +14.0% |
Q3 2016 | $6,677,100,000 | +116960.0% | 270,000 | -3.6% | 1.06% | +4.7% |
Q2 2016 | $5,704,000 | +38.5% | 280,000 | +3.7% | 1.01% | +24.0% |
Q1 2016 | $4,118,000 | +6.4% | 270,000 | -6.2% | 0.82% | +39.7% |
Q4 2015 | $3,871,000 | -21.9% | 288,000 | -18.5% | 0.58% | -25.9% |
Q3 2015 | $4,957,000 | -30.0% | 353,328 | -15.3% | 0.79% | -7.1% |
Q2 2015 | $7,081,000 | +29.9% | 417,000 | -7.5% | 0.85% | -7.5% |
Q1 2015 | $5,450,000 | +161.8% | 450,800 | +79.7% | 0.92% | +52.4% |
Q4 2014 | $2,082,000 | +13.0% | 250,800 | +18.3% | 0.60% | +11.9% |
Q3 2014 | $1,842,000 | -25.9% | 212,000 | -6.6% | 0.54% | -27.0% |
Q2 2014 | $2,486,000 | +41.5% | 227,000 | +15.5% | 0.74% | +40.0% |
Q1 2014 | $1,757,000 | +3.5% | 196,537 | -12.7% | 0.53% | -20.6% |
Q4 2013 | $1,697,000 | – | 225,000 | – | 0.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |